Literature DB >> 2474177

Inhibitory effect of pancreastatin on pancreatic exocrine secretion in the conscious rat.

A Funakoshi1, K Miyasaka, R Nakamura, K Kitani, K Tatemoto.   

Abstract

The effect of newly discovered pancreastatin on pancreatic secretion stimulated by a diversion of bile-pancreatic juice (BPJ) from the intestine was examined in the conscious rat. Exogenous pancreastatin infusion (20, 100 and 200 pmol/kg.h) inhibited pancreatic protein and fluid outputs during BPJ diversion in a dose-dependent manner. Pancreastatin did not affect plasma cholecystokinin (CCK) concentrations. Pancreastatin (100 pmol/kg.h) inhibited CCK-stimulated pancreatic secretion, but did not inhibit secretin-stimulated pancreatic secretion. Pancreastatin alone, however, did not affect basal pancreatic secretion. In contrast, pancreastatin (10(-10)-10(-7)M) did not suppress CCK-stimulated amylase release from isolated rat pancreatic acini. These results indicate that pancreastatin has an inhibitory action on exocrine function of the pancreas. This action may not be mediated by direct mechanisms and nor via an inhibition of CCK release. It is suggested that pancreastatin may play a role in the regulation of the intestinal phase of exocrine pancreatic secretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474177     DOI: 10.1016/0167-0115(89)90257-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  4 in total

1.  Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla.

Authors:  A Watkinson; A C Jönsson; M Davison; J Young; C M Lee; S Moore; G J Dockray
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

2.  Plasma pancreastatin responses after intrajejunal infusion of liquid meal in patients with chronic pancreatitis.

Authors:  A Funakoshi; K Tateishi; H Shinozaki; K Miyasaka; T Ito; H Wakasugi
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

Review 3.  Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.

Authors:  W E Fisher; P Muscarella; L G Boros; W J Schirmer
Journal:  Int J Pancreatol       Date:  1998-12

Review 4.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.